The biomarker conundrum for adaptive dosing/tumour control …oh and that pesky cumulative risk! Written by Hitesh Mistry on August 14, 2020
Modeling collaterally sensitive drug cycles Shaping heterogeneity to allow adaptive therapy Written by Nara Yoon on July 17, 2020
A Personal Perspective on Being Black in America and Academia A call to address racial injustice as a community Written by Stacey Finley on June 16, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer Behind the Paper Written by Dan Nichol on May 06, 2020
A spatial game to simulate evolutionary treatments An evolutionary game theory approach to the emergence of treatment-resistance Written by Alex Bakos on April 14, 2020
Employing a Standard in Predictive Model Development Behind the paper Written by Renee Brady-Nicholls on April 09, 2020
K for carrying capacity? A brief discussion of why we shouldn't forget about death in the logistic growth equation Written by Maximilian Strobl on April 04, 2020
Practicing for the worst-case scenario of cancer biology Behind the paper Written by Noemi Andor on March 31, 2020
Pan-cancer immune portraits help personalize radiotherapy Behind the paper Written by Heiko Enderling on February 17, 2020
